Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
64
BCS Quote, Financials, Valuation and Earnings
Last price:
$25.30
Seasonality move
:
3.93%
Day range:
$24.31 - $25.31
52-week range:
$12.14 - $27.70
Dividend yield:
1.77%
P/E ratio:
11.02x
P/S ratio:
2.04x
P/B ratio:
1.00x
Volume:
14.5M
Avg. volume:
6M
1-year change:
74.07%
Market cap:
$87.3B
Revenue:
$72B
EPS (TTM):
$2.30
Analysts' Opinion
-
Consensus RatingBarclays PLC has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.21, Barclays PLC has an estimated upside of 3.56% from its current price of $25.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.80 representing 100% downside risk from its current price of $25.31.
Fair Value
-
According to the consensus of 2 analysts, Barclays PLC has 3.56% upside to fair value with a price target of $26.21 per share.
BCS vs. S&P 500
-
Over the past 5 trading days, Barclays PLC has underperformed the S&P 500 by -2.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Barclays PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Barclays PLC has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Barclays PLC reported revenues of $9.4B.
Earnings Growth
-
Barclays PLC has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Barclays PLC reported earnings per share of $0.46.
Enterprise value:
675.3B
EV / Invested capital:
1.00x
Price / LTM sales:
2.04x
EV / EBIT:
56.21x
EV / Revenue:
17.59x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
-0.42x
Price / Operating cash flow:
0.40x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.39%
Net Income Margin (TTM):
21.29%
Return On Equity:
9.82%
Return On Invested Capital:
2.09%
Operating Margin:
27.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $31.5B | $34.2B | $38.4B | $8.9B | $9.4B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $8.2B | $10.6B | $12.5B | $2.3B | $2.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.36 | $1.84 | $2.30 | $0.34 | $0.46 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1T | $969B | $980.8B | $1T | $1.1T | |
| Total Assets | $1.9T | $1.8T | $1.9T | $1.9T | $2.1T | |
| Current Liabilities | $537.1B | $524.8B | $488.3B | $504.9B | $506.2B | |
| Total Liabilities | $1.8T | $1.8T | $1.8T | $1.8T | $2T | |
| Total Equity | $78.3B | $67.3B | $74.7B | $75.7B | $88.1B | |
| Total Debt | $193.7B | $210.6B | $193.1B | $176.6B | $563.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $47.4B | $27.1B | |
| Cash From Investing | -- | -- | -- | -$20.6B | -$5.6B | |
| Cash From Financing | -- | -- | -- | $209.4M | $5B | |
| Free Cash Flow | $231B | $210B | $182.7B | $47.4B | $27.1B | |
BCS
Sector
Market Cap
$87.3B
$520.8M
Price % of 52-Week High
91.37%
91.24%
Dividend Yield
1.77%
1.48%
Shareholder Yield
-78.08%
3.03%
1-Year Price Total Return
74.07%
8.16%
Beta (5-Year)
0.957
0.450
Dividend yield:
1.77%
Annualized payout:
$0.45
Payout ratio:
65.27%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$26.04
200-day SMA
Buy
Level
$21.02
Bollinger Bands (100)
Buy
Level
20.82 - 25.74
Chaikin Money Flow
Buy
Level
1.4B
20-day SMA
Sell
Level
$26.35
Relative Strength Index (RSI14)
Sell
Level
43.38
ADX Line
Sell
Level
23.32
Williams %R
Neutral
Level
-70.5015
50-day SMA
Sell
Level
$25.53
MACD (12, 26)
Buy
Level
0.10
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
768.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5272)
Sell
CA Score
(Annual)
Level (-2.4681)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1844)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Barclays PLC is a bank holding company, which engages in the provision of retail banking, credit cards, corporate and investment banking, and wealth management services. It operates through the following segments: Barclays United Kingdom (UK), Barclays United Kingdom (UK) Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, Barclays United States (US) Consumer Bank, and Head Office. The Barclays UK segment represents businesses that sit within the UK ring-fenced bank entity, Barclays Bank UK PLC, and comprises personal banking, business banking and Barclaycard consumer UK. The Barclays UK Corporate Bank segment focuses on bringing together lending, trade and working capital, liquidity, payments, and FX solutions for UK corporate clients. The Barclays Private Bank and Wealth Management segment serves UK and international private banking clients. The Barclays Investment Bank segment incorporates the global markets, investment banking, and international corporate banking businesses. The Barclays US Consumer Bank segment relates to co-branded credit card issuer and financial services partner in the United States. The Head Office segment comprises central support, central treasury operations, Barclays Execution Services assets and legacy businesses. The company was founded on 1690 and is headquartered in London, the United Kingdom.
Stock Forecast FAQ
In the current month, BCS has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BCS average analyst price target in the past 3 months is $26.21.
-
Where Will Barclays PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Barclays PLC share price will rise to $26.21 per share over the next 12 months.
-
What Do Analysts Say About Barclays PLC?
Analysts are divided on their view about Barclays PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Barclays PLC is a Sell and believe this share price will drop from its current level to $23.80.
-
What Is Barclays PLC's Price Target?
The price target for Barclays PLC over the next 1-year time period is forecast to be $26.21 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BCS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Barclays PLC is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of BCS?
You can purchase shares of Barclays PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Barclays PLC shares.
-
What Is The Barclays PLC Share Price Today?
Barclays PLC was last trading at $25.30 per share. This represents the most recent stock quote for Barclays PLC. Yesterday, Barclays PLC closed at $25.31 per share.
-
How To Buy Barclays PLC Stock Online?
In order to purchase Barclays PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BCS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BCS
Sector
P/E ratio
11.02x
12.49x
PEG ratio
0.45x
0.32x
P/B ratio
1.00x
1.14x
Price / LTM sales
2.04x
1.85x
Growth Metrics
BCS
Sector
Revenue growth
5.45%
5.46%
Earnings growth
33.58%
10.33%
Revenue (5-year growth)
15.25%
8.67%
Earnings forecast
$0.43
$0.64
Profitability
BCS
Sector
Profitability FY 2025
--
--
Return on invested capital
2.09%
5.19%
Return on assets
0.39%
1.03%
Return on equity
9.82%
9.9%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Apr
28
Estimated Next Earnings Date
May
12
Balance Sheet
BCS
Sector
Total cash
$309.7B
$406.5M
Short term investments
--
$190.5M
Total assets
$2.1T
$3.1B
Long term debt
$563.5B
$55.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
